Jugulotympanic Paragangliomas: 75 Years of Evolution in Understanding
Overview
Authors
Affiliations
Jugulotympanic paragangliomas were first described approximately 75 years ago. Since that time, there has been considerable evolution in knowledge of tumor biology, methods of classification, and appropriate management strategies. This paper attempts to summarize these gains in information.
Wang S, Zhang B, Lou Z, Hu Y, Wang J, Wang J Heliyon. 2024; 10(15):e35478.
PMID: 39170307 PMC: 11336777. DOI: 10.1016/j.heliyon.2024.e35478.
Chaushu H, Butrus F, Oron Y, Handzel O, Abu-Eta R, Muhanna N Eur Arch Otorhinolaryngol. 2024; 281(10):5119-5127.
PMID: 38722318 DOI: 10.1007/s00405-024-08720-y.
Tumor progression in tympanojugular paragangliomas: the role of radiotherapy and wait and scan.
Fancello G, Fancello V, Ehsani D, Porpiglia V, Piras G, Caruso A Eur Arch Otorhinolaryngol. 2024; 281(6):2779-2789.
PMID: 38184495 DOI: 10.1007/s00405-023-08413-y.
Zhao P, Zhang Y, Lin F, Kong D, Feng Y, Dai C Sci Rep. 2023; 13(1):885.
PMID: 36650202 PMC: 9845292. DOI: 10.1038/s41598-023-27821-y.
Chen H, Zhu W, Li X, Xue L, Wang Z, Wu H J Cancer Res Clin Oncol. 2017; 143(6):953-960.
PMID: 28255624 DOI: 10.1007/s00432-017-2355-0.